A Spin-Labeled Derivative of Gossypol.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
21 Oct 2024
Historique:
received: 20 09 2024
revised: 18 10 2024
accepted: 18 10 2024
medline: 26 10 2024
pubmed: 26 10 2024
entrez: 26 10 2024
Statut: epublish

Résumé

Gossypol and its derivatives arouse interest due to their broad spectrum of biological activities. Despite its wide potential application, there is no reported example of gossypol derivatives bearing stable radical functional groups. The first gossypol nitroxide hybrid compound was prepared here via formation of a Schiff base. By this approach, synthesis of a gossypol nitroxide conjugate was performed by condensation of gossypol with a 4-amino-TEMPO (4-amino-2,2,6,6-tetramethylpiperidin-1-oxyl) free radical, which afforded the target product in high yield. Its structure was proven by a combination of NMR and EPR spectroscopy, infrared spectroscopy, mass spectrometry, and high-resolution mass spectrometry. In addition, the structure of the gossypol nitroxide was determined by single-crystal X-ray diffraction measurements. In crystals, the paramagnetic Schiff base exists in an enamine-enamine tautomeric form. The tautomer is strongly stabilized by the intra- and intermolecular hydrogen bonds promoted by the resonance of π-electrons in the aromatic system. NMR analyses of the gossypol derivative proved that in solutions, the enamine-enamine tautomeric form prevailed. The gossypol nitroxide at micromolar concentrations suppressed the growth of tumor cells; however, compared to gossypol, the cytotoxicity of the obtained conjugate was substantially lower.

Identifiants

pubmed: 39459334
pii: molecules29204966
doi: 10.3390/molecules29204966
pii:
doi:

Substances chimiques

Gossypol KAV15B369O
Spin Labels 0
Antineoplastic Agents 0
Cyclic N-Oxides 0
Schiff Bases 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Andrey V Stepanov (AV)

N.D. Zelinsky Institute of Organic Chemistry, Leninsky Ave. 47, Moscow 119991, Russia.

Vladimir N Yarovenko (VN)

N.D. Zelinsky Institute of Organic Chemistry, Leninsky Ave. 47, Moscow 119991, Russia.

Darina I Nasyrova (DI)

N.D. Zelinsky Institute of Organic Chemistry, Leninsky Ave. 47, Moscow 119991, Russia.

Lyubov G Dezhenkova (LG)

Gause Institute of New Antibiotics, Bolshaya Pirogovskaya St. 11, Moscow 119021, Russia.

Igor O Akchurin (IO)

Gause Institute of New Antibiotics, Bolshaya Pirogovskaya St. 11, Moscow 119021, Russia.
D. Mendeleev University of Chemical Technology of Russia, Miusskaya Sq. 9, Moscow 125047, Russia.

Mickhail M Krayushkin (MM)

N.D. Zelinsky Institute of Organic Chemistry, Leninsky Ave. 47, Moscow 119991, Russia.

Valentina V Ilyushenkova (VV)

N.D. Zelinsky Institute of Organic Chemistry, Leninsky Ave. 47, Moscow 119991, Russia.

Andrey E Shchekotikhin (AE)

Gause Institute of New Antibiotics, Bolshaya Pirogovskaya St. 11, Moscow 119021, Russia.

Evgeny V Tretyakov (EV)

N.D. Zelinsky Institute of Organic Chemistry, Leninsky Ave. 47, Moscow 119991, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH